0RGO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
DMS Imaging SA is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. Its products include gp-ASIT+, which is developed for the treatment of allergic rhinitis due to grass pollen; hdm-ASIT+, for the treatment of house dust mite allergy; and pnt-ASIT+for the treatment of peanut allergy. The company was founded by Thierry Legon in 1997 and is headquartered in Liege, Belgium.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
0RGO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company